432 / 473
LEGAL DEVELOPMENTS
419
benefited from the block exemption under the Communiqué no
2002/2. (11.04.2013, 13-21/282-133)
• The Board decided that the notified Distribution Agreement
concluded between Roche Müstahzarları Sanayi A.Ş. and Drogsan
İlaçları San. ve Tic. A.Ş. benefited from the block exemption
under the Communiqué no 2002/2. (11.04.2013, 13-21/288-138)
• The Board granted a certificate of negative clearance to the
“Advertisement Agreement” signed between Merck Sharp Dohme
İlaçları Ltd. Şti. and Roche Müstahzarları San. A.Ş. pursuant to
Article 8 of Law No. 4054. (06.05.2013, 13-25/342-159)
• As a result of the examination conducted in response to the
request for the grant of an indefinite individual exemption to
the ATM Bank Card Share Platform Protocol concluded for the
purpose of opening the ATM networks to the services of cash
withdrawal and inquiring the balance of the customers of other
banks through their bank cards, the Board decided that the ATM
Bank Card Share Platform Protocol is within the scope of Article
4 of Act No. 4054; however, an individual exemption could be
granted to the aforementioned agreement since it fulfilled all of
the conditions stipulated under paragraph 1 of Article 5 of Act No.
4054. (06.05.2013, 13-25/347-163)
• As a result of the examination conducted in response to the request
for the grant of an individual exemption to the agreement on the
granting of exclusive authority to Biovesta İlaçları Ltd. Şti. for the
distribution, marketing, sale and promotion of certain medicine
owned by Abdi İbrahim İlaç San. ve Tic. A.Ş., the Board decided
that a certificate of negative clearance could not be granted to the
agreement, dated 23.1.2013, which granted exclusive authority to
Biovesta İlaçları Ltd. Şti. for the distribution, marketing, sale and
promotion of certain medicine owned by Abdi İbrahim İlaç San.
ve Tic. A.Ş, and that said agreement could not benefit from the
block exemption granted by the “Block Exemption Communiqué
on Vertical Agreements, No: 2002/2” since the agreement is signed
between competitors; however, an individual exemption could be